SCHEMBL9890340

SCHEMBL9890340

c1ccc(-c2cc(-c3ccccc3)cc(-c3ccc4oc5cc6oc7ccc(-n8c9ccccc9c9ccccc98)cc7c6cc5c4c3)c2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLA2G2A P14555 4/20 0.40
PLA2G4A P47712 4/20 0.40
KDM4E B2RXH2 3/20 0.40
ATM Q13315 2/20 0.40
L3MBTL1 Q9Y468 2/20 0.40
PRKDC P78527 4/20 0.39
PLA2G10 O15496 1/20 0.39
PGR P06401 1/20 0.35
HDAC4 P56524 1/20 0.35
NPC1 O15118 2/20 0.33
RAB9A P51151 2/20 0.33
EDNRB P24530 1/20 0.33
EDNRA P25101 1/20 0.33
MAOA P21397 1/20 0.33
TSPO P30536 1/20 0.33
MEN1 O00255 2/20 0.33
MAPT P10636 2/20 0.33
KMT2A Q03164 2/20 0.33
AHR P35869 1/20 0.33
ALDH1A1 P00352 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9890332 0.97 PRKDC (0.42) PLA2G2APLA2G4AKDM4EATML3MBTL1
SCHEMBL9890324 0.97 KDM4E (0.42) PLA2G2APLA2G4AKDM4EATML3MBTL1
SCHEMBL9890336 0.97 KDM4E (0.42) PLA2G2APLA2G4AKDM4EATML3MBTL1
SCHEMBL9890343 0.97 KDM4E (0.42) PLA2G2APLA2G4AKDM4EATML3MBTL1
SCHEMBL9890089 0.96 KDM4E (0.41) PLA2G2APLA2G4AKDM4EATML3MBTL1
SCHEMBL9890371 0.96 KDM4E (0.40) PLA2G2APLA2G4AKDM4EATML3MBTL1
SCHEMBL9890372 0.95 PLA2G2A (0.40) PLA2G2APLA2G4AKDM4EATML3MBTL1
SCHEMBL9890366 0.95 KDM4E (0.41) PLA2G2APLA2G4AKDM4EATML3MBTL1
SCHEMBL9890095 0.93 PLA2G2A (0.42) PLA2G2APLA2G4AKDM4EATML3MBTL1
SCHEMBL9890019 0.93 ATM (0.45) PLA2G2APLA2G4AKDM4EATML3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130020563-A1 POLYCYCLIC COMPOUNDS AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2013-01-24 US disclosed
US-20130020563-A1 POLYCYCLIC COMPOUNDS AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2013-01-24 US disclosed
US-8318323-B2 Polycyclic compounds and organic electroluminescence device employing the same IDEMITSU KOSAN CO., LTD. (JP) 2012-11-27 US disclosed
US-8318323-B2 Polycyclic compounds and organic electroluminescence device employing the same IDEMITSU KOSAN CO., LTD. (JP) 2012-11-27 US disclosed
US-20120138915-A1 ORGANIC ELECTROLUMINESCENCE DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2012-06-07 US disclosed
US-20120138915-A1 ORGANIC ELECTROLUMINESCENCE DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2012-06-07 US disclosed
US-20100012931-A1 POLYCYCLIC COMPOUNDS AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2010-01-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130020563-A1 POLYCYCLIC COMPOUNDS AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME KCNC1, EED, BMI1 PLA2G2A 4239/4885PLA2G4A 4728/4885KDM4E 990/4885
US-20100012931-A1 POLYCYCLIC COMPOUNDS AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME KCNC1, EED, BMI1 PLA2G2A 4239/4885PLA2G4A 4728/4885KDM4E 990/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.